#shareprice

Posts mentioning hashtag #shareprice

Below are all the posts — topics as well as replies — that mention the hashtag #shareprice.

Mention #shareprice in your post to continue the discussion!

IBM stock down 40 points in 9 days

Told you so. 2-2-26 $315. 2-11-26 $275. Stay away. Stay far far away.

A putrid odor fills the air,
A scent of ruin and despair,
Like rotten eggs and old, wet trash,
It hits the nose with sudden crash.
It lingers in the stagnant room,
A heavy, green, and choking gloom,
That makes you gag and hold your breath,
A foul scent, mimicking death.


Kyndryl’s Collapse Isn’t a Dip Worth Buying

Barron's: 2/10/26 -

  • Kyndryl Holdings shares plunged 55% to $10.59 after multiple executive departures and an SEC review of accounting practices.
  • Guggenheim Partners downgraded the stock to Neutral, citing unanswered questions and weak fiscal third-quarter results.
  • The company cut its fiscal 2026 revenue outlook to a 2% to 3% decline and reduced free cash flow guidance to $350 million.

Kyndryl’s future is too uncertain for investors to feel comfortable, according to Guggenheim Partners.

If there is one thing investors dislike most, it is uncertainty. Kyndryl Holdings’ future now looks more uncertain than ever after a historic selloff on Monday, analysts say.

Shares of the IT infrastructure company plunged 55% to $10.59 after Kyndryl announced the departures of Chief Financial Officer David Wyshner, General Counsel Edward Sebold, and Global Controller Vineet Khurana. The company also disclosed that it is reviewing its accounting practices following voluntary document requests from the Securities and Exchange Commission.

Guggenheim Partners downgraded Kyndryl stock to Neutral from Buy and withdrew its price target. In a research note, analyst Jonathan Lee said the announcements, combined with weak fiscal third-quarter results, raised more questions than answers.

The stock rebounded 5.3% on Tuesday to $11.15.

Lee said investors likely anticipated a weak earnings report from the former IBM spinoff but were unprepared for the abrupt exit of key legal and financial executives or the disclosure of material weaknesses in internal controls over financial reporting. The SEC review, in particular, is expected to remain an overhang on the stock.

Kyndryl said it is developing a remediation plan but offered no details, noting that additional information would be provided in a delayed quarterly securities filing.

“We expect investors to continue questioning execution and credibility until management provides an update on material weaknesses,” Lee wrote.

The company’s updated guidance also failed to reassure investors. Kyndryl now expects fiscal 2026 revenue to decline 2% to 3%, compared with a prior forecast of 1% growth. It also cut its midpoint free cash flow forecast to $350 million, down from $550 million.

According to Lee, the revised outlook casts doubt on Kyndryl’s long-term goal of generating $1 billion in adjusted free cash flow by 2028. Restoring confidence in that target will require a credible management team capable of executing a turnaround.

For now, analysts recommend caution. J.P. Morgan double-downgraded Kyndryl to Underweight from Overweight, and Oppenheimer cut its rating to Perform from Outperform.

https://www.barrons.com/articles/kyndryl-stock-downgrade-accounting-review-7245a725


CVE stock price???

Well the boost to the stock price was certainly short by lived. Strathcona made out like bandits. They didn’t even get MEG and they had a higher and more sustained bump to share price than Cenovus. It would seem the street clearly doesn’t like CVE’s messaging and/or the ones delivering the message.


Jingle Shell, Jingle Shell

My hope for 2026 is that Shell finally sticks with a reorg and gives it proper time to play out. No more knee-je-k layoffs and asset sales every 6-12 months. If you have to change course that often you don’t know what you’re doing.
Could also work on staff appreciation and driving the share price up but I won’t hope for that much.


I could easily get this share price to $60 per share

Cant believe how poor the Management and Shareholders are in this company.

I could turn the situation around easily, spin off the insurance to Private Equity or IPO for $2billion, which will pay off all the debt.

Your left with a cash company generating Free Cash Flow of $400 million with no debt on a PE of 20 thats $8 Billion= $48 per share.

I would not hire any new folks, natural wastage would get rid of 20% of the workforce in the year, i would get rid of the several layers of management, the existing employees would retrain if they were offered a good pay incentive, FCF would rise to $450 milion, another $10+ on the share price to $60, then get some bolt on Acquisitions.

If Fernandez isnt going to grow the Company this is about to happen soon.


As the market rips higher $T just sits there flat or red

Every major index is at all time highs, and AT&T can’t even catch a tailwind. The stock is a DOG, and nobody’s buying what Stinky’s selling. The Street has zero confidence in this leadership team or their “strategy”

Face it, this stock stanks.


Nobody Mentioned This

SB in response to one of the canned questions; "it's impossible to forecast quarter to quarter for Wall Street". Wait, what?!!! I thought that is your job. Then he followed with a telling slip of the tongue; "That's why companies go private and can come back out on the other side". He's done a yoemans job of plowing the share price into the ground and now he's hoping for a buyer to execute the plan his boss Carl brought him in here to do in the first place.


Waiting for the move

So, I've been holding on to my Shel shares waiting for them to announce the move to the US. I figure that's the last rabbit to pull out of the old hat, and then the show is over. Honestly, shares have been on a rise lately and its been a decade since they've been this high and there is no discernible reason for the price to be this high. I've sold some just in case this is the highest they get. But I am speculating that the price jumps when Shell moves to the US. I mean its not value, its not growth potential, its not the buy-backs, its not the leadership and their vision. We're all waiting and hoping for the announcement that makes the shares jump so we can sell. Shows over soon I hope.


DXC shares

Looking at the DXC share price. Fair to say it's seen better days, I'm losing money If I current withdraw, but I risk losing it all going the way we are. What's people thoughts? Can management fix this ? Currently sitting at a 30%-40% loss with the share incentive program, and risk losing more if I withdraw due to tax but would rather have something, id even gamble it at this rate.


Fresh blood

TU has filled almost every senior role recently with an external hire. The clear message being sent that the people who were around for the IPO and drove the share price into the 80's are incompetent. Yet the share price has languished in the 80's since Chris took the helm 5 years ago. So I'm wondering why "fresh blood" applies to everybody but him? I sincerely hope this upcoming GLM is his last.


What is happening with Pershing?

I've noticed this year in particular a highly unfavorable balance of BD deconversions/terminations, relative to the amount of firms onboarded. I know Pershing is only one slice of the BNY pie. Between the exodus of clients under our clearing business and the seemingly unmitigated failure that the money pit known as Wove Investor appears to be so far, I can't say these are good signs, in spite of the current share price of $109.53 (9/26/25).